Cesar Libanati
Cesar Libanati
UCB Pharma
Verified email at ucb.com
Title
Cited by
Cited by
Year
Denosumab for prevention of fractures in postmenopausal women with osteoporosis
SR Cummings, JS Martin, MR McClung, ES Siris, R Eastell, IR Reid, ...
New England Journal of Medicine 361 (8), 756-765, 2009
32212009
Romosozumab in postmenopausal women with low bone mineral density
MR McClung, A Grauer, S Boonen, MA Bolognese, JP Brown, ...
New England Journal of Medicine 370 (5), 412-420, 2014
9382014
Romosozumab treatment in postmenopausal women with osteoporosis
F Cosman, DB Crittenden, JD Adachi, N Binkley, E Czerwinski, S Ferrari, ...
New England Journal of Medicine 375 (16), 1532-1543, 2016
8042016
Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 …
JP Brown, RL Prince, C Deal, RR Recker, DP Kiel, LH De Gregorio, ...
Journal of bone and mineral research 24 (1), 153-161, 2009
6952009
Vertebral bone density in children: effect of puberty.
V Gilsanz, DT Gibbens, TF Roe, M Carlson, MO Senac, MI Boechat, ...
Radiology 166 (3), 847-850, 1988
4531988
Strength training increases regional bone mineral density and bone remodeling in middle-aged and older men
A Menkes, S Mazel, RA Redmond, K Koffler, CR Libanati, CM Gundberg, ...
Journal of applied physiology 74 (5), 2478-2484, 1993
4361993
Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension
S Papapoulos, R Chapurlat, C Libanati, ML Brandi, JP Brown, ...
Journal of Bone and Mineral Research 27 (3), 694-701, 2012
3702012
Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate
E Seeman, PD Delmas, DA Hanley, D Sellmeyer, AM Cheung, E Shane, ...
Journal of Bone and Mineral Research 25 (8), 1886-1894, 2010
2922010
The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study
S Papapoulos, K Lippuner, C Roux, CJF Lin, DL Kendler, EM Lewiecki, ...
Osteoporosis international 26 (12), 2773-2783, 2015
2532015
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open …
BL Langdahl, C Libanati, DB Crittenden, MA Bolognese, JP Brown, ...
The Lancet 390 (10102), 1585-1594, 2017
2032017
Effects of denosumab on bone turnover markers in postmenopausal osteoporosis
R Eastell, C Christiansen, A Grauer, S Kutilek, C Libanati, MR McClung, ...
Journal of Bone and Mineral Research 26 (3), 530-537, 2011
2012011
Effects of strength training on bone mineral density: hormonal and bone turnover relationships
AS Ryan, MS Treuth, MA Rubin, JP Miller, BJ Nicklas, DM Landis, ...
Journal of applied physiology 77 (4), 1678-1684, 1994
1941994
Racial differences in bone density between young adult black and white subjects persist after adjustment for anthropometric, lifestyle, and biochemical differences
B Ettinger, S Sidney, SR Cummings, C Libanati, DD Bikle, IS Tekawa, ...
The Journal of Clinical Endocrinology & Metabolism 82 (2), 429-434, 1997
1791997
National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges
D Bauer, J Krege, N Lane, E Leary, C Libanati, P Miller, G Myers, ...
Osteoporosis International 23 (10), 2425-2433, 2012
1692012
Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures
M Austin, YC Yang, E Vittinghoff, S Adami, S Boonen, DC Bauer, ...
Journal of Bone and Mineral Research 27 (3), 687-693, 2012
1592012
Differing effects of denosumab and alendronate on cortical and trabecular bone
RM Zebaze, C Libanati, M Austin, A Ghasem-Zadeh, DA Hanley, ...
Bone 59, 173-179, 2014
1312014
Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX
EV McCloskey, H Johansson, A Oden, M Austin, E Siris, A Wang, ...
Journal of Bone and Mineral Research 27 (7), 1480-1486, 2012
1272012
Development, validation, and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids
S Mohan, C Libanati, C Dony, K Lang, N Srinivasan, DJ Baylink
The Journal of Clinical Endocrinology & Metabolism 80 (9), 2638-2645, 1995
1251995
Biochemical markers of bone turnover for the clinical assessment of bone metabolism
AK Taylor, SA Lueken, C Libanati, DJ Baylink
Rheumatic Disease Clinics of North America 20 (3), 589-607, 1994
1181994
Quantitative computed tomography (QCT) of the forearm using general purpose spiral whole-body CT scanners: accuracy, precision and comparison with dual-energy X-ray …
K Engelke, C Libanati, Y Liu, H Wang, M Austin, T Fuerst, B Stampa, ...
Bone 45 (1), 110-118, 2009
1162009
The system can't perform the operation now. Try again later.
Articles 1–20